Corporate Overview

Corporate Name

SCOHIA PHARMA, Inc.

Head Office

26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan

Establishment

March 6, 2017

Capital

8,201Million yen

Organization Chart

Board Members and Auditor

Yoichi Okumura President and CEO
Yukio Yamada Executive Director and CSO
Keiichi Kiyota Executive Director and CFO
Koichi Ashida Director
Takehiko Sawabe Director
Toshiaki Kudo Outside Auditor
Tsuyoshi Dai Outside Auditor
Kenji Maekawa Outside Auditor

Shareholders

INCJ, Ltd.
Takeda Pharmaceutical Company Limited
MEDIPAL HOLDINGS CORPORATION

Scientific Advisers

Steven R. Smith, M.D.
Chief Scientific Officer/SVP, Florida Hospital Research Service
Scientific Director, Translational Institute for Metabolism & Diabetes
Past President of The Obesity Society

Randy J. Seeley, Ph.D.
H.K. Ransom Professor of Surgery, Internal Medicine and Nutritional Sciences
University of Michigan
Director, Michigan Nutrition Obesity Research Center (MNORC)

Masaomi Nangaku, M.D. , Ph.D.
Professor and Head, Division of Nephrology and Endocrinology,
The University of Tokyo Graduate School of Medicine